NDC Package 45865-825-12 Rizatriptan Benzoate

View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
45865-825-12
Package Description:
2 BLISTER PACK in 1 CARTON / 6 TABLET in 1 BLISTER PACK
Product Code:
Proprietary Name:
Rizatriptan Benzoate
Usage Information:
Rizatriptan benzoate tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. Information related to usage of rizatriptan benzoate in pediatric patients (6 to 17 years old) is approved for Merck & Co., Inc.'s Rizatriptan Benzoate Tablets.  However, due to Merck & Co., Inc.'s marketing exclusivity rights, this drug product is not labeled with that pediatric patient (6 to 17 years old) usage information.Limitations of Use Rizatriptan benzoate tablets should only be used where a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with rizatriptan benzoate tablets, the diagnosis of migraine should be reconsidered before rizatriptan benzoate tablets is administered to treat any subsequent attacks.Rizatriptan benzoate tablets are not indicated for use in the management of hemiplegic or basilar migraine [see Contraindications (4)]. Rizatriptan benzoate tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of rizatriptan benzoate tablets have not been established for cluster headache.
11-Digit NDC Billing Format:
45865082512
NDC to RxNorm Crosswalk:
  • RxCUI: 314209 - rizatriptan benzoate 10 MG Oral Tablet
  • RxCUI: 314209 - rizatriptan 10 MG Oral Tablet
  • RxCUI: 314209 - rizatriptan 10 MG (as rizatriptan benzoate 14.53 MG) Oral Tablet
  • Labeler Name:
    Medsource Pharmaceuticals
    Sample Package:
    No
    Start Marketing Date:
    12-31-2012
    Listing Expiration Date:
    12-31-2022
    Exclude Flag:
    I
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 45865-825-12?

    The NDC Packaged Code 45865-825-12 is assigned to a package of 2 blister pack in 1 carton / 6 tablet in 1 blister pack of Rizatriptan Benzoate, labeled by Medsource Pharmaceuticals. The product's dosage form is and is administered via form.

    Is NDC 45865-825 included in the NDC Directory?

    No, Rizatriptan Benzoate with product code 45865-825 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Medsource Pharmaceuticals on December 31, 2012 and its listing in the NDC Directory is set to expire on December 31, 2022 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 45865-825-12?

    The 11-digit format is 45865082512. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-245865-825-125-4-245865-0825-12